Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months.

Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months.

Item
http://www.wikidata.org/entity/Q37469307
EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.EV71 vaccine, an invaluable gift for children.Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches.Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial.Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trialUpdate of enterovirus 71 infection: epidemiology, pathogenesis and vaccine.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.
P2860

Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months.

Item
http://www.wikidata.org/entity/Q37469307
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@en
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@nl
type
label
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@en
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@nl
prefLabel
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@en
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Immunogenicity, safety, and lo ...... children aged 6 to 59 months.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932